Actively Recruiting
Colorectal Cancer Dataset in Xijing Hospital From 2011
Led by Xijing Hospital · Updated on 2024-03-13
40000
Participants Needed
1
Research Sites
1930 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital.
CONDITIONS
Official Title
Colorectal Cancer Dataset in Xijing Hospital From 2011
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pathologically confirmed colorectal adenocarcinoma, including hereditary colorectal cancer syndromes such as Lynch syndrome, familial adenocarcinoma tumor polyposis, Peutz Jeghers syndrome, juvenile polyposis syndrome, and serrated polyposis syndrome
- Patients treated at Xijing Hospital with complete medical and pathological records
- Colorectal cancer diagnosis between 2013 and 2023
You will not qualify if you...
- Other colorectal malignancies besides adenocarcinoma
- Malignant tumors invading the colon and rectum from adjacent organs
- Malignant tumors metastasizing to the colon and rectum from distant organs
- Benign colorectal lesions
- Patients with recurrent colorectal cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fourth Military Medical University
Xi'an, Shaanxi, China
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here